Top 5 High Dividend Stocks To Buy For 2014

Stocks that pay dividends have never been more popular, especially among investors looking for as much income as they can generate from their portfolios. If you're a dividend investor, you need to know that the stocks you choose will give you dependable income not only now but well into the future.

What not to focus on
The mistake that many dividend investors make is to pay too much attention to current yield. Admittedly, if you need income right now, then the temptation to get instant gratification from a high-yielding dividend stock can be overwhelming.

But all too often, stocks that pay high dividends end up having to cut their payouts. By contrast, stocks that have demonstrated their ability provide strong growth in their dividends -- even if their yields aren't as high -- give investors more assurance that those stocks will be able to sustain their payouts going forward.

With that in mind, let's turn to four stocks that have attractive yields of 3% or more yet have been able to produce impressive dividend growth at a 10% or greater annual clip for the past decade.

Top Semiconductor Stocks To Own Right Now: Spectrum Pharmaceuticals Inc.(SPPI)

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company, primarily focuses on oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. It markets Zevalin, a prescribed form of cancer therapy, radioimmunotherapy; and Fusilev, a novel folate analog formulation and the pharmacologically active isomer of the racemic compound, calcium leucovorin. The company?s drugs in late stage development include Apaziquone, an anti-cancer agent; and Belinostat, a histone deacytelase inhibitor. Its drugs in development also include Ozarelix a luteinizing hormone releasing hormone antagonist, which is in Phase II clinical stage; SPI-1620, a peptide agonist of endothelin B receptors, which is in Phase I clinical stage; and RenaZorb, a lanthanum-based nanoparticle phosphate binding agent, which is in preclinical stage. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is based in Henderson, Nevada.

Advisors' Opinion:

• [By Rich Smith]

  Spectrum Pharmaceuticals (NASDAQ: SPPI  ) has found itself a new Executive Vice President, a new Chief Financial Officer, and a new Principal Accounting�Officer. They're all the same person.

Top 5 High Dividend Stocks To Buy For 2014: PhotoMedex Inc.(PHMD)

PhotoMedex, Inc., together with its subsidiaries, operates as a skin health company in North America and internationally. It offers disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers. The company provides no!no! hair removal products; professional products, including capital equipment to physicians and skin care specialists; XTRAC laser products for the treatment of psoriasis and vitiligo; NEOVA formulations for premature skin aging due to UV-induced DNA damage; Omnilux Light-emitting diode (LED) systems to treat wrinkles, acne, minor muscle pain, and pigmented lesions; Lumi�e light therapy equipment, a non-invasive skin care solution for use in non-medical applications primarily salons and spas; and topical lotions to improve the appearance of fine lines, wrinkles, skin tone, and blemishes. It also provides home-use devices under the no!no! brand for various indications, including hair removal, acne treatment, and ski n rejuvenation; and a professional product line for acne clearance, skin tightening, psoriasis care, and hair removal to physician clinics and spas. In addition, the company engages in the development, manufacture, and sale of surgical products, including proprietary free-beam and Contact Laser Systems for surgery. Further, it sells surgical disposables and accessories to hospitals and surgery centers; and repairs, maintains, and provides replacement parts for the company?s products. The company is headquartered in Montgomeryville, Pennsylvania.

Advisors' Opinion:

• [By Lauren Pollock]

  Skin-health company PhotoMedex Inc.(PHMD) issued a dour third-quarter report as it didn’t log any consumer sales to its Japanese distributor, which changed its business model and affected other companies besides PhotoMedex. Unless it generates revenue from Japan, the company’s current-quarter sales are poised to fall short of consensus views. Shares dropped 10% to $11.47 premarket.

• [By Lisa Levin]

  PhotoMedex (NASDAQ: PHMD) shares rose 2.47% to $13.27. The volume of PhotoMedex shares traded was 659% higher than normal. PhotoMedex lifted its Q4 revenue forecast.

• [By Garrett Cook]

  In trading on Thursday, healthcare shares were relative laggards, down on the day by about 0.62 percent. Meanwhile, top decliners in the sector included Thoratec (NASDAQ: THOR), down 30 percent, and PhotoMedex (NASDAQ: PHMD), off 15.11 percent.

Top 5 High Dividend Stocks To Buy For 2014: eLong Inc.(LONG)

eLong, Inc. operates as an online travel service provider in the People?s Republic of China. The company provides its customers with travel information and the ability to book rooms, air tickets, vacation packages, and other travel related services utilizing call center and Web-based distribution technologies. It facilitates the customers to book rooms in approximately 10,000 hotels in 450 cities across China, and fulfills air ticket reservations in approximately 80 cities across China. In addition, the company offers the ability to book rooms at approximately 100,000 hotels outside of China; and provides the customers informative content relevant to hotel and air travel decisions, including tourist and event site destination information, hotel facility information, and photos. eLong markets its services through online marketing, traditional media advertising, co-marketing with established brands of other companies, and direct marketing. The company was founded in 1999 and is headquartered in Beijing, the People?s Republic of China. eLong, Inc. operates as a subsidiary of Expedia Asia Pacific Limited.

Advisors' Opinion:

• [By Shareholders Unite]

  The main on-line competitors are:

  Qunar.com, a travel website owned by Baidu (BIDU) and a few venture fundseLong (LONG), backed by Tencent (TCEHY.PK) and Expedia (EXPE). Analyst expect it to generate $163M in revenue next year

  That is pretty serious competition, needless to say. Having the backing of Baidu or Expedia offers several advantages, but Ctrip is the biggest and most established company. It's quite difficult to compare Qunar.com to Ctrip, for the simple sake that Qunar is a private company. However, there can be little doubt that it constitutes serious competition:

• [By Faisal Humayun]

  Positive Clarification on eLong (LONG)

  There were rumours in the recent past that Expedia is considering selling its 65% stake in eLong. On July 7, 2014, Expedia announced that the talk on selling the stake was indeed a rumour and Expedia remains a long-term investor in eLong to support eLong's drive to become the leading Chinese travel site.

• [By Seth Jayson]

  eLong (Nasdaq: LONG  ) reported earnings on May 13. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), eLong beat expectations on revenues and beat expectations on earnings per share.

• [By Belinda Cao]

  The Bloomberg China-US Equity Index (HSCEI) of the most-traded Chinese stocks in the U.S. added 0.3 percent to 103.21 yesterday. Renren, owner of a real-name social network website, jumped to the highest level since August as volumes surged. Web travel agency Elong Inc. (LONG) soared 20 percent. China Southern Airlines Co. (ZNH), Asia�� biggest carrier by passenger numbers, fell the most in a week and China Eastern Airlines Corp. slid to a three-week low.

Top 5 High Dividend Stocks To Buy For 2014: Wartsila Oyj Abp (WRT1V.HE)

Wartsila Oyj Abp is a Finland-based company. Its operations are divided into four segments: Power Plants, Ship Power, Services and PowerTech. The Power Plants segment offers multi-fuel solutions for power generation markets, such as gas power plants, dual-fuel power plants, oil power plants and liquid biofuel power plants, among others. The Ship Power segment offers a range of products and services to both shipyards and ship owners, such as medium-speed and low-speed engines, seals and bearings, automation systems, ship design and ballast water treatment systems, among others. The Services segment offers solutions, such as basic support, installation and commissioning, performance optimization and upgrades, among others. The PowerTech segment comprises research and development for medium-speed engines and other operations, with a focus on gas, environmental solutions and Smart Power Generation drives. It has operations in more than 160 locations in over 70 countries around the world. Advisors' Opinion:

• [By Robert Wall var popups = dojo.query(".socialByline .popC"); popups.forEach(fu]

  The British company tried to strengthen its maritime engine business through a $10 billion takeover of Finland�� W盲rtsil盲 Oyj (WRT1V.HE) which rebuffed Rolls-Royce’s preliminary approach. The attempted acquisition of a company of that size surprised investors who hadn�� realized expansion was on management�� agenda so soon after its full takeover of Tognum, a German engineering company originally acquired in partnership with Daimler.